Are hypertensive women with type 2 diabetes treated with RAS inhibitors as often as men? A cross-sectional study in France
Women with type 2 diabetes are less likely than men to receive a prescription for RAS inhibitors, although this drug class is recommended as first-line therapy in this population.
Authors
- Sofiane Kab (ORCID: https://orcid.org/0000-0001-6041-9602)
- Raphaëlle Delpech
- Laurent Rigal (ORCID: https://orcid.org/0000-0001-6807-2738)
- Virginie Ringa
- Marie Zins (ORCID: https://orcid.org/0000-0002-4540-4282)
- Jeanne Sassenou (ORCID: https://orcid.org/0000-0002-0023-1189)
- Sylvain Paquet (ORCID: https://orcid.org/0000-0001-7784-6109)
Institutions
- Inserm (FR)
- Université Paris-Saclay (FR)
- Centre de recherche en Epidémiologie et Santé des Populations (FR)
- Laboratoire d'études sur les monothéismes (FR)
- Bicêtre Hospital (FR)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1136/bmjopen-2024-092205
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Institut National de la Santé et de la Recherche Médicale
- Conservatoire National des Arts et Métiers